tiprankstipranks
Trending News
More News >
Advertisement

XUDV - ETF AI Analysis

Compare

Top Page

XUDV

Franklin U.S. Dividend Multiplier Index ETF (XUDV)

Rating:69Neutral
Price Target:
XUDV, the Franklin U.S. Dividend Multiplier Index ETF, has a solid overall rating driven mainly by strong, income-focused holdings like Verizon, Oneok, Pfizer, and Bristol-Myers Squibb, which combine healthy cash flows, reasonable valuations, and attractive dividends with generally positive business outlooks. However, weaker names such as Kraft Heinz, which faces declining revenues and bearish momentum, and more leveraged or challenged companies like Altria and Ford, modestly weigh on the fund’s appeal. The main risk factor is that many top holdings are mature, dividend-heavy businesses, so the ETF is more exposed to sector-specific challenges and slower growth than a more diversified, growth-oriented fund.
Positive Factors
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of their returns over time.
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors, including financials, consumer defensive, health care, industrials, energy, and technology, which helps reduce the impact of weakness in any single area.
Negative Factors
High U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering little geographic diversification.
Mixed Performance Among Top Holdings
Some of the largest positions, such as Kraft Heinz, Verizon, and Edison International, have shown weak or negative performance year-to-date, which can drag on overall returns.
Meaningful Weight in Defensive and Rate-Sensitive Sectors
Significant exposure to financials, utilities, and consumer defensive stocks may make the fund sensitive to changes in interest rates and economic conditions.

XUDV vs. SPDR S&P 500 ETF (SPY)

XUDV Summary

Franklin U.S. Dividend Multiplier Index ETF (XUDV) is a U.S. stock fund that follows the VettaFi New Frontier U.S. Dividend Select Index. It focuses on companies that pay higher-than-average dividends across many sectors, including financials, consumer staples, health care, and energy. Well-known holdings include United Parcel Service (UPS), Pfizer, Verizon, and Ford. Someone might invest in XUDV to seek regular income from dividends while staying diversified across many industries. A key risk is that stock prices and dividend payments can go up or down, so your investment value and income are not guaranteed.
How much will it cost me?The Franklin U.S. Dividend Multiplier Index ETF (XUDV) has an expense ratio of 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down while offering diversified exposure to high-yield dividend stocks.
What would affect this ETF?The Franklin U.S. Dividend Multiplier Index ETF (XUDV) could benefit from stable or declining interest rates, which often make dividend-paying stocks more attractive to investors seeking income. Additionally, its exposure to defensive sectors like Consumer Defensive and Health Care may provide resilience during economic downturns. However, rising interest rates or regulatory changes affecting key sectors like Financials and Energy could negatively impact the ETF's performance.

XUDV Top 10 Holdings

XUDV leans heavily on classic U.S. dividend payers, with United Parcel Service and Oneok helping to pull the fund forward thanks to rising momentum and solid cash flows. Health care names like Pfizer and Bristol-Myers are steady contributors, offering a defensive backbone with generally supportive trends. On the flip side, consumer staples giant Kraft Heinz looks like it’s losing its edge, and Verizon has been lagging, acting as a bit of a weight on returns. Overall, the ETF is broadly diversified across U.S. sectors but tilts toward income-rich financials, consumer defensive, and health care names.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Verizon5.60%$3.32M$206.31B14.38%
81
Outperform
United Parcel5.41%$3.21M$97.60B0.97%
72
Outperform
Altria Group5.33%$3.16M$111.70B25.18%
64
Neutral
Pfizer4.97%$2.95M$155.62B5.72%
74
Outperform
Edison International4.94%$2.93M$27.48B32.96%
77
Outperform
Kraft Heinz4.60%$2.73M$28.15B-19.60%
48
Neutral
Oneok4.38%$2.60M$53.87B-12.51%
82
Outperform
Bristol-Myers Squibb4.03%$2.39M$122.90B8.64%
78
Outperform
LyondellBasell3.21%$1.90M$18.02B-27.78%
52
Neutral
Ford Motor3.06%$1.82M$56.37B48.29%
71
Outperform

XUDV Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
27.54
Positive
100DMA
26.75
Positive
200DMA
25.92
Positive
Market Momentum
MACD
0.47
Negative
RSI
64.57
Neutral
STOCH
77.14
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XUDV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 28.39, equal to the 50-day MA of 27.54, and equal to the 200-day MA of 25.92, indicating a bullish trend. The MACD of 0.47 indicates Negative momentum. The RSI at 64.57 is Neutral, neither overbought nor oversold. The STOCH value of 77.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XUDV.

XUDV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$59.79M0.09%
$73.40M0.35%
$57.91M0.97%
$42.14M0.26%
$30.43M0.45%
$20.78M0.40%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
XUDV
Franklin U.S. Dividend Multiplier Index ETF
29.04
4.33
17.52%
FDIV
MarketDesk Focused U.S. Dividend ETF
WBIY
WBI Power Factor High Dividend ETF
NUDV
Nuveen ESG Dividend ETF
DIVY
Sound Equity Income ETF
PAYR
Federated Hermes Enhanced Income ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement